✨ Free AI Report
Virbac SA: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Virbac SA
Company Research

Virbac SA: Business Overview, Financials & Competitive Analysis

Virbac SA scores 7/10 on the AskCyborg Cyborg Score (Strong). Strong incumbent in global animal health with attractive growth tailwinds from companion animal demand and strategic M&A capability. Virbac demonstrates solid fundamentals with consistent double-digit revenue growth, a leading market position as the 6th largest veterinary pharmaceutical company, and strong profitability metrics. Recent leadership transition and global diversification provide growth.

What is Virbac SA's industry? Virbac SA (corporate.virbac.com) operates in Veterinary Pharmaceuticals & Animal Health. AskCyborg classifies Virbac SA under Veterinary Pharmaceuticals & Animal Health in its company registry.

Virbac is a French company dedicated to animal health located in Carros, near Nice. The company is the 6th largest veterinarian pharmaceutical group with a turnover of 1,397 million euros in 2024 (62% companion animal...

7/ 10Strong

Cyborg Score thesis

Strong incumbent in global animal health with attractive growth tailwinds from companion animal demand and strategic M&A...

Read the full analyst-debate transcript →
Industry Veterinary Pharmaceuticals & Animal Health
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Virbac SA Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Virbac SA

AskCyborg analysts argue the bull and bear cases for Virbac SA across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Virbac SA OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Virbac SA Overview

Pro stress-test →

Virbac is a French company dedicated to animal health located in Carros, near Nice. The company is the 6th largest veterinarian pharmaceutical group with a turnover of 1,397 million euros in 2024 (62% companion animal and 38% food producing animal). The company serves a global customer base including veterinarians, farmers, and pet owners across multiple continents.

Strategic Profile

Pro stress-test →

Virbac manufactures and sells a range of products and services for companion and farm animals globally, offering vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. In 2024, Virbac's revenue was 1.40 billion, an increase of 12.07% compared to the previous year's 1.25 billion.

Competitive Landscape

Pro stress-test →

Virbac is one of the 10 biggest veterinary pharmaceutical companies in the world. The company competes in the fragmented animal health sector alongside multinational pharma players with veterinary divisions and specialized animal health companies. Strong regional presence in Europe and Latin America provides competitive advantage alongside global scale competitors.

Industry Context

Virbac SA operates in Veterinary Pharmaceuticals & Animal Health.

Key facts

Founded: 1968 · Headquarters: Carros, France · Revenue: $1.40B · Market cap: $3.62B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Virbac SA.

  • Strong revenue growth momentum: 12.07% YoY growth in 2024, with Q2 2025 showing +6.4% organic growth at constant rates
  • Dual revenue model: 62% companion animals (pets) and 38% livestock, diversifying demand across consumer and agricultural sectors
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • September 2025Paul Martingell appointed as new CEO of Virbac group
  • June 2025Q2 2025 revenue reached €363.1 million, marking +6.4% increase at constant exchange rates
  • +1 moreTrack every material event for Virbac SA as it happens. Explore monitoring →
Get alerted when Virbac SA has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Animal Health DivisionMajor multinational competitor in veterinary pharmaceuticals→Elanco Animal HealthSpecialized animal health company with strong companion animal focus→Zoetis Inc.Leading global animal health pharmaceutical company→

Compare Virbac SA with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Virbac SA operates in Veterinary Pharmaceuticals & Animal Health. See how the rest of the sector scores on the Cyborg framework.

Browse Veterinary Pharmaceuticals & Animal Health research →
NEW · MCP server

Ask your AI assistant about Virbac SA

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Virbac SA and its top competitor on Cyborg Score”
“What did Virbac SA do this quarter?”
“Is Virbac SA a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Virbac SA do?+
Virbac is a French company dedicated to animal health located in Carros, near Nice. The company is the 6th largest veterinarian pharmaceutical group with a turnover of 1,397 million euros in 2024 (62% companion animal...
What is Virbac SA's Cyborg Score?+
Virbac SA has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Virbac SA's main competitors?+
Named competitors include Animal Health Division, Elanco Animal Health, Zoetis Inc.. The full competitive landscape is in the AskCyborg report.
How can I get the full Virbac SA research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Virbac SA research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Virbac SA over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Veterinary Pharmaceuticals & Animal Health research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Zoetis Inc.